Cutaneous Sarcoidosis during Pegylated Interferon alpha and Ribavirin Treatment of Chronic Hepatitis C – a Case Report
Authors:
E. Honsová 1; E. Sticová 1; J. Šperl 2
Authors‘ workplace:
Pracoviště klinické a transplantační patologie IKEM, Praha
1; Klinika hepatogastroenterologie IKEM, Praha
2
Published in:
Čes.-slov. Patol., 43, 2007, No. 1, p. 27-30
Category:
Original Article
Overview
Interferon-induced sarcoidosis is well documented. We report a case of sarcoidosis in a patient with hepatitis C virus infection treated with pegylated interferon alpha and ribavirin. The patient developed cutaneous sarcoidosis about 6 months after beginning of the combination therapy. Spontaneous regression of the lesions was noted after discontinuation of the treatment. Interferon-alpha is known to stimulate T helper cells with a TH-1 profile immune response, which is the key immunologic event of a sarcoid granuloma formation. In addition to its antiviral action, ribavirin also enhanced the TH-1 response. Incidence of drug induced sarcoidosis may be underreported, because many symptoms of sarcoidosis mimic the side-effects of interferon as fever, myalgias, arthralgias, fatigue and symptoms of pulmonary diseases.
Key words:
hepatitis C – interferon-alpha – sarcoidosis
Labels
Anatomical pathology Forensic medical examiner ToxicologyArticle was published in
Czecho-Slovak Pathology
![Issue 1](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/4c9cddb441787d6e86202e0299632347.jpeg)
2007 Issue 1
Most read in this issue
- Primary Hodgkin Lymphoma of the Stomach – a Case Report
- Assessment of Sentinel Nodes in Breast Cancer by Rapid Peroperative Biopsy and Immunohistochemistry in Serial Sectioning
- Perivascular Epithelioid Cell Tumor (PEComa) of the Liver: a Case Report and Review of the Literature
- Cardiovascular Pathology – New Informations